You may find that profiles you want to connect define the right shapes ... the polyhedron—it will produce the least twisted possible result. This algorithm has quadratic run time so it can be slow ...

Vertex halts VX-264 trials after missing efficacy goals but continues advancing zimislecel, a potential treatment for severe ...

Vertex Software faces strong competition and slower growth, leading to a neutral rating. See why VERX stock remains pricey ...

Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge ...

Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to ...

Morgan Stanley raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $462 from $459 and keeps an Equal Weight rating on the ...

Vertex Pharmaceuticals (VRTX) announced several updates on the company’s type 1 diabetes portfolio. Vertex has completed enrollment and dosing ...

According to Reuters, the expanded partnership now enables Reddit (RDDT) to use Google’s Vertex AI, an AI development platform by Google Cloud that enables its users to build, deploy and scale ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy ... and impaired hypoglycaemia awareness, meaning they find it hard to spot the telltale signs of declining ...

So how do we find a sweet spot where we are able to function — by which I mean staying conscious, thinking reasonably clearly, taking in information, responding with both logic and empathy ...